Osteoarthritis affects millions of Americans, yet treatment options have changed very little over the last three decades. Could a new approach help shift the conversation from managing symptoms to treating the disease itself?

More than 50 million Americans are living with osteoarthritis, making it one of the most prevalent chronic diseases in the country. Yet despite its enormous impact on mobility, pain, and overall quality of life, treatment options have remained largely unchanged for decades. Many patients find themselves navigating a cycle of pain medications, injections, and eventually joint replacement surgery, often with limited long-term solutions. 

In this segment of Health Uncensored, Dr. Drew explores the growing need for innovation in osteoarthritis treatment with Biosplice Therapeutics CEO Erich Horsley and Chief Medical Officer Dr. Yusuf Yazici. Together, they discuss the scale of the osteoarthritis crisis, the challenges patients face in managing the disease, and the limitations of currently available therapies. 

As millions of Americans continue searching for better answers, this discussion highlights the evolving future of osteoarthritis care and the importance of expanding treatment possibilities for patients and their families.